← 홈

CGT

275개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 275개
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting FLT3 chimeric antigen receptor (T cell injection targeting FLT3 chimeric antigen receptor)

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleMariella EnocPhase 2

TCR alfa beta T cell depletion (TCR alfa beta T cell depletion)

Acute Lymphoblastic Leukemia; Leukemia Acute Myeloid - AML · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

TCR reserved and Power3 (SPPL3, TCR reserved and Power3, TCR reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T cell)

Acute Lymphocytic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

TSLPR-CART (TSLPR-CART)

B-All; Acute Lymphoblastic Leukemia · B-All

#B-All#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstale920th Hospital of Joint Logisti…Phase 1

Target CD7 CAR-T cells (Target CD7 CAR-T cells)

T-cell Acute Lymphoblastic Leukemia; T-lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleWuhan Bio-Raid Biotechnology Co…Phase 1

Third generation CAR-T cells (Third generation CAR-T cells)

B Cell Lymphoma; Acute Lymphoblastic Leukemia · B Cell Lymphoma

#BCellLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleWuhan Bio-Raid Biotechnology Co…Phase 1

Third-generation anti-CD123 CAR-T cells (Third-generation anti-CD123 CAR-T cells)

CD123+ Acute Myeloid Leukemia · CD123+ Acute Myeloid Leukemia

#CD123+AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART7 cells (ThisCART7 cells)

T-Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-Acute Lymphoblastic Leukemia

#T-AcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

UCART019 (UCART019)

B Cell Leukemia; B Cell Lymphoma · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleCellectis S.A.Phase 1

UCART123v1.2 (UCART123v1.2)

Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleInstitut de Recherches Internat…Phase 1

UCART19 (UCART19)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleInstitut de Recherches Internat…Phase 1

UCART19 follow-up (UCART19 follow-up)

Advanced Lymphoid Leukemia · Advanced Lymphoid Leukemia

#AdvancedLymphoidLeukemia#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 1

Universal CD7-specific CAR gene-engineered T cells (Universal CD7-specific CAR gene-engineered T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells (Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells)

B Cell Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleVor BiopharmaPhase 2

VCAR33 (VCAR33)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 DISCONTINUED
CGTBiologicstaleXijing HospitalPhase 1

XYF19 CAR-T cell (XYF19 CAR-T cell)

Leukemia Lymphocytic Acute (ALL) in Relapse; Leukemia Lymphocytic Acute (All) Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleNational University Health Syst…Phase 1

anti-CD19 redirected NK cells (anti-CD19 redirected NK cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleShanghai First Song Biotechnolo…Phase 1

anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells (anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells)

Relapsed/refractory Lymphoma; Relapsed/Refractory Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChinese PLA General HospitalPhase 2

anti-CD19/22-CAR vector-transduced T cells (anti-CD19/22-CAR vector-transduced T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleChinese PLA General HospitalPhase 2

anti-CD20-CAR vector-transduced autologous T cells (anti-CD20-CAR vector-transduced autologous T cells)

Hematopoietic/Lymphoid Cancer; Adult Acute Lymphoblastic Leukemia in Remission · CD20

#CD20#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE

13 / 14 페이지

← 이전다음 →